Scaling Engineering Biology: From Lab to Real‑World Impact

How can the UK scale engineering biology? Explore the infrastructure, partnerships and investment needed to turn innovation into impact.

Engineering biology is a major strength for the UK, but turning world-leading research into economic value depends on the ability to scale.

You can also watch it on YouTube

Allow YouTube content?

This page contains content provided by YouTube. We ask for your permission before anything is loaded, as they may be using cookies and other technologies for tracking and advertising. You may want to read their cookie policy and privacy policy before accepting. To view this content, choose ‘Accept and continue’.

Accept and continue

In this episode of People in Innovation, our host Steve Bagshaw, Chair of the High Value Manufacturing Catapult, is joined by Dan Wallis, Production Operations Manager at Azotic, and Alex Smith, Director of Biotechnology at CPI, to explore why bridging the gap between discovery and deployment is essential to ensure UK innovation translates into jobs, companies and supply chains.

Using Azotic’s natural nitrogen‑fixation technology as a case study, the conversation explores how collaboration with CPI helped move the technology from lab‑scale to commercial readiness, enabling real-world impact in sustainable agriculture. We also look at the role of CPI and the wider High Value Manufacturing Catapult network in providing critical scale-up infrastructure, and why funding gaps and limited access remain major barriers for SMEs in the UK’s engineering biology sector.

Join this exciting discussion on the possibilities ahead and the steps we must take to get there.

More Podcasts

UK bioeconomy and engineering biology: From innovation to real-world impact

Transforming Healthcare with Engineering Biology: From Lab to Patient

Engineering biology: The next industrial revolution

All podcasts